Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Group education improves self-management of adrenal insufficiency in patients and their relative.

Endocrine connections·2026
Same author

Increased mortality in chronic hypoparathyroidism: a nationwide cohort study in Sweden.

Endocrine connections·2026
Same author

Development of a Digital Phenotype for Immune-Related Colitis.

JCO clinical cancer informatics·2026
Same author

Partially Ablative Body Radiation Therapy Versus Standard Palliative Radiation Therapy for Locally Advanced Bulky Unresectable Sarcomas.

Advances in radiation oncology·2026
Same author

Pre-emptive <i>DPYD</i> genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Same author

C no more: a prospective single-arm study to evaluate the effectiveness of a nurse and peer-led mobile model of hepatitis C testing and treatment at community corrections offices.

Health & justice·2026

Related Experiment Videos

Medication chart intervention improves inpatient thromboembolism prophylaxis.

David S H Liu1, Margaret M W Lee2, Tim Spelman3

  • 1Department of General Surgery, The Royal Melbourne Hospital, Parkville.

Chest
|July 23, 2011
PubMed
Summary

The Australian National Inpatient Medication Chart (NIMC) intervention significantly increased the use of appropriate venous thromboembolism (VTE) prophylaxis in hospital patients. This improvement in VTE prophylaxis quality was sustained 12 months postintervention.

Related Experiment Videos

Area of Science:

  • Healthcare quality improvement
  • Clinical intervention effectiveness
  • Patient safety

Background:

  • Inpatient venous thromboembolism (VTE) prophylaxis is frequently underused, leading to preventable morbidity and mortality.
  • The Australian National Inpatient Medication Chart (NIMC) intervention was developed to address underuse through a multifaceted approach.
  • NIMC incorporates risk stratification, contraindication screening, and prescription prompts to optimize VTE prophylaxis.

Purpose of the Study:

  • To evaluate the effectiveness of the NIMC intervention in improving VTE prophylaxis quality.
  • To assess the impact of the NIMC intervention on VTE disease incidence and prophylaxis-related complications.
  • To determine the sustainability of improved VTE prophylaxis rates postintervention.

Main Methods:

  • A retrospective analysis of 2,371 inpatient admissions was conducted.
  • Data were collected for medical and surgical patients for one year before and after the NIMC intervention.
  • Key outcomes included prophylaxis use, timing, guideline adherence, VTE incidence, and complication rates.

Main Results:

  • NIMC intervention significantly increased prophylaxis use in medical (52.7% to 66.5%) and surgical (77.5% to 89.1%) patients.
  • Prophylaxis initiation on admission and adherence to guidelines also significantly improved postintervention.
  • While VTE incidence and complication rates did not significantly change, the quality of prophylaxis was enhanced.

Conclusions:

  • The multifaceted NIMC intervention effectively increased appropriate and timely VTE prophylaxis in inpatients.
  • The observed improvements in VTE prophylaxis quality were sustained 12 months after implementation.
  • NIMC represents a successful low-cost strategy for enhancing inpatient VTE prophylaxis.